Richard J. Edmondson

9.9k total citations · 2 hit papers
128 papers, 3.6k citations indexed

About

Richard J. Edmondson is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Richard J. Edmondson has authored 128 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Reproductive Medicine, 51 papers in Oncology and 41 papers in Obstetrics and Gynecology. Recurrent topics in Richard J. Edmondson's work include Ovarian cancer diagnosis and treatment (58 papers), Endometrial and Cervical Cancer Treatments (41 papers) and PARP inhibition in cancer therapy (25 papers). Richard J. Edmondson is often cited by papers focused on Ovarian cancer diagnosis and treatment (58 papers), Endometrial and Cervical Cancer Treatments (41 papers) and PARP inhibition in cancer therapy (25 papers). Richard J. Edmondson collaborates with scholars based in United Kingdom, Australia and United States. Richard J. Edmondson's co-authors include Nicola J. Curtin, Christine K. Schmidt, Oliver G. Schmidt, Mariana Medina‐Sánchez, Emma J. Crosbie, Asima Mukhopadhyay, John Monaghan, Suzanne Kyle, Melanie Powell and Ahmed Elattar and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Richard J. Edmondson

117 papers receiving 3.6k citations

Hit Papers

Refining prognosis and identifying targetable pathways fo... 2015 2026 2018 2022 2015 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
    2015 341 citations Ellen Stelloo, Tjalling Bosse et al. Modern Pathology profile →
  2. Engineering microrobots for targeted cancer therapies from a medical perspective
    2020 322 citations Richard J. Edmondson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard J. Edmondson United Kingdom 36 1.4k 1.3k 1.2k 978 507 128 3.6k
Toru Sugiyama Japan 34 1.3k 1.0× 1.3k 0.9× 3.0k 2.5× 1.8k 1.8× 479 0.9× 234 5.1k
Nicolaì Maass Germany 33 1.8k 1.3× 1.3k 1.0× 553 0.5× 652 0.7× 1.1k 2.2× 274 4.9k
Pamela L. Strissel Germany 35 671 0.5× 2.3k 1.7× 401 0.3× 1.1k 1.2× 537 1.1× 104 4.7k
Margaret M. Steinhoff United States 34 1.0k 0.7× 874 0.7× 1.5k 1.2× 1.2k 1.2× 953 1.9× 77 3.9k
Shashikant Lele United States 38 3.4k 2.5× 2.2k 1.6× 1.3k 1.1× 1.0k 1.0× 1.1k 2.1× 158 7.8k
Ji‐Hong Hong Taiwan 40 1.3k 1.0× 1.2k 0.9× 448 0.4× 1.1k 1.1× 561 1.1× 135 5.4k
Peter A. van Dam Belgium 49 3.6k 2.6× 2.8k 2.1× 574 0.5× 644 0.7× 2.5k 4.9× 186 7.2k
Benedict B. Benigno United States 27 553 0.4× 1.1k 0.9× 702 0.6× 229 0.2× 415 0.8× 61 2.4k
Noriomi Matsumura Japan 41 3.7k 2.7× 2.5k 1.8× 2.1k 1.7× 1.2k 1.3× 1.4k 2.7× 212 7.9k
Martin K. Oehler Australia 40 1.0k 0.7× 2.2k 1.7× 874 0.7× 783 0.8× 737 1.5× 164 4.5k

Countries citing papers authored by Richard J. Edmondson

Since Specialization
Citations

This map shows the geographic impact of Richard J. Edmondson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard J. Edmondson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard J. Edmondson more than expected).

Fields of papers citing papers by Richard J. Edmondson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard J. Edmondson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard J. Edmondson. The network helps show where Richard J. Edmondson may publish in the future.

Co-authorship network of co-authors of Richard J. Edmondson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard J. Edmondson. A scholar is included among the top collaborators of Richard J. Edmondson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard J. Edmondson. Richard J. Edmondson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Booth, Jonathan, Nicholas Wood, Jo Morrison, et al.. (2025). Developing a platform to investigate the heterogeneity of outcomes for patients with ovarian cancer. BMJ Open Quality. 14(Suppl 1). e002742–e002742. 1 indexed citations
2.
Gaitskell, Kezia, Nicholas Wood, Christina Fotopoulou, et al.. (2025). Advanced epithelial ovarian cancer in older patients. International Journal of Gynecological Cancer. 35(10). 102017–102017.
3.
Morgan, Jennie, et al.. (2024). Patient and clinician priorities for information on treatment outcomes for advanced ovarian cancer: a Delphi exercise. Journal of Gynecologic Oncology. 35(5). e63–e63. 1 indexed citations
4.
5.
Morgan, Robert D., Xin Wang, Jurjees Hasan, et al.. (2024). Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer. British Journal of Cancer. 131(12). 1919–1927. 5 indexed citations
6.
7.
Blanc‐Durand, Félix, Christopher M. Kramer, Etienne Rouleau, et al.. (2023). 788P Molecular profiling of p53 mutant endometrial cancer reveals distinct subgroups with opportunities for personalized therapeutic approaches. Annals of Oncology. 34. S529–S530.
8.
9.
Cummins, Carole, Joanna Long, Janos Balega, et al.. (2022). Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study. Cancers. 14(18). 4362–4362. 8 indexed citations
10.
Veen, Elke M. van, Olivia Smith, William G. Newman, et al.. (2021). Dominant‐negative pathogenic variant BRIP1 c. 1045G >C is a high‐risk allele for non‐mucinous epithelial ovarian cancer: A case‐control study. Clinical Genetics. 101(1). 48–54. 4 indexed citations
11.
Sundar, Sudha, Carole Cummins, Joanna Long, et al.. (2021). Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER‐2 cohort study. BJOG An International Journal of Obstetrics & Gynaecology. 129(7). 1122–1132. 19 indexed citations
12.
Allen, Jennifer L., Matthew Gittins, James M. Bolton, et al.. (2020). PROgesterone Therapy for Endometrial Cancer Prevention in Obese Women (PROTEC) Trial: A Feasibility Study. Cancer Prevention Research. 14(2). 263–274. 12 indexed citations
13.
Sundar, Sudha, Sunil Kumar, Junyu Long, et al.. (2020). PATIENT REPORTED OUTCOMES (PRO) AFTER SURGERY IN ADVANCED OVARIAN CANCER - INITIAL RESULTS FROM THE INTERNATIONAL, PROSPECTIVE, MULTICENTER SOCQER 2 STUDY. Queen Mary Research Online (Queen Mary University of London). 1 indexed citations
14.
Crosbie, Emma J., et al.. (2019). Epithelial ovarian cancer risk: A review of the current genetic landscape. Clinical Genetics. 97(1). 54–63. 41 indexed citations
15.
O’Sullivan, Richard, R O’Donnell, J. C. Murray, et al.. (2016). Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib. Clinical Cancer Research. 23(8). 2050–2060. 62 indexed citations
16.
Gool, Inge C. van, Ellen Stelloo, Remi A. Nout, et al.. (2016). Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer. Modern Pathology. 29(2). 174–181. 66 indexed citations
17.
Gool, Inge C. van, Ellen Stelloo, Remi A. Nout, et al.. (2015). PROGNOSTIC VALUE OF L1CAM EXPRESSION AND ITS ASSOCIATION WITH MUTANT P53 EXPRESSION IN HIGH-RISK ENDOMETRIAL CANCER PATIENTS: A TRANSPORTEC STUDY. International Journal of Gynecological Cancer. 25. 258–259. 1 indexed citations
18.
Mukhopadhyay, Asima, Elizabeth Ruth Plummer, Ahmed Elattar, et al.. (2012). Clinicopathological Features of Homologous Recombination–Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival. Cancer Research. 72(22). 5675–5682. 95 indexed citations
19.
Mukhopadhyay, Asima, Ahmed Elattar, Sarah Wilkinson, et al.. (2010). Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors. Clinical Cancer Research. 16(8). 2344–2351. 207 indexed citations
20.
Edmondson, Richard J., et al.. (2010). Liquid based cytology improves the positive predictive value of glandular smears compared to conventional cytology.. PubMed. 31(3). 288–90. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toru Sugiyama Breakdown of academic impact, for papers by Nicolaì Maass Breakdown of academic impact, for papers by Pamela L. Strissel Breakdown of academic impact, for papers by Margaret M. Steinhoff Breakdown of academic impact, for papers by Shashikant Lele Breakdown of academic impact, for papers by Ji‐Hong Hong Breakdown of academic impact, for papers by Peter A. van Dam Breakdown of academic impact, for papers by Benedict B. Benigno Breakdown of academic impact, for papers by Noriomi Matsumura Breakdown of academic impact, for papers by Martin K. Oehler
Rankless by CCL
2026